Evaluation of Upper Esophageal Sphincter Motor Activity in Patients with Extra Esophageal Reflux Symptoms

Scientific Institute for Research Hospitalization and Healthcare (IRCCS)

Status: Active, not recruiting

Conditions: Gastroesophageal Reflux Disease

Treatments: Other: gastroenterology and otolaryngological evaluation

Study type: Observational

Funder types: Other

Identifiers

NCT06773702

VAM-SES-SEER2019

Details and patient eligibility

About

To evaluate the presence of motor changes of the upper esophageal sphincter detectable by high-resolution manometry in patients with oropharyngeal symptoms referable to extra-esophageal reflux manifestations.

Full description

Gastroesophageal reflux disease (GERD) is a condition that occurs when the passage of gastric contents into the esophagus becomes clinically symptomatic and results in the appearance of complications. The incidence is higher in countries with high socioeconomic status; in fact, the prevalence in the US is estimated to be between 15 and 30 percent of the population compared with 5 to 10 percent in eastern countries such as China. 1 Typical manifestations are heartburn and acid regurgitation; however, in some cases it may manifest with extraesophageal symptoms, termed atypical, resulting from the involvement of anatomical areas of otolaryngological and pulmonary relevance.

According to the 2006 Montreal classification (Figure 1), still the reference of gastroesophageal reflux disease, the disease can manifest with:

1. esophageal syndrome, subdivided into:

   • symptomatic, without esophageal injury (typical reflux syndrome, Chest pain syndrome)
   • syndrome with esophageal damage (esophagitis, stenosis, Barrett's esophagus and Adenocarcinoma of the esophagus)

2. extraesophageal syndrome, subdivided into:

   • association with established reflux disease (chronic cough, laryngitis, asthma, dental erosions)
   • association with proposed reflux disease (pharyngitis, sinusitis, idiopathic pulmonary fibrosis, recurrent otitis media).

A study performed by Francis DO in the United States in 2013 showed how the management of extra esophageal reflux disease substantially burdens public spending. In fact, it was found that the cost for the first year of evaluation and treatment of patients presenting with extra esophageal reflux symptoms is five times higher than the management of typical esophageal reflux disease. The cause of this discrepancy is precisely the absence of a definitive diagnosis and standard treatment, which result in difficult management of the disease.

While there is ample literature regarding the association between MRGE and alteration of the lower esophageal sphincter, little is described about the correlation between alterations in pharyngo-laryngeal motor activity and the upper esophageal sphincter in patients with extraesophageal reflux disease symptoms.

Indeed, it is hypothesized that the reflux of acidic material at the level of the larynx may be due to a dysfunction of the sphincter that acts as an escape valve between the esophagus and pharyngo-larynx. With the development of high-resolution manometry, which, unlike conventional manometry, has no spatial gaps and allows for a faithful representation of esophageal motor function in time and space, a detailed study of oropharyngeal and upper esophageal sphincter motor activity can be achieved

The observational, non-interventional nature of the study is based on two main elements:

1. the evaluation of data obtained from high-resolution esophageal manometry in patients with extra-esophageal reflux symptoms
2. the comparison of data obtained from high-resolution esophageal manometry with 24-hour PH-impedancemetry and otolaryngological scores of laryngopharyngeal reflux (Reflux symptom Index, Reflux Finding Score) Patients participating in the study will not undergo any procedures beyond normal daily clinical practice; likewise, the clinical variables that will be collected for the study are those that are commonly collected by the physician in daily clinical practice.

Enrollment: 50 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria.

• Age between 18 and 80 years.
• Patients with laryngopharyngeal reflux symptoms.
• Obtaining informed consent. Exclusion criteria.
• Patients with tobacco habit.
• Patients with occupational exposure to irritants (artisans and industrial workers).

Trial design

50 participants in 1 patient group

Patients with laryngopharyngeal reflux symptoms

Description:

Gastroenterological evaluation by esophageal manometry, 24-hour Ph impedance testing, Otolaryngological evaluation by laryngoscopy

Treatment:

Other: gastroenterology and otolaryngological evaluation